• Specific Year
    Any

POISONS AND THERAPEUTIC GOODS REGULATION 2008 - REG 92 Supply by pharmacists of liquid methadone or buprenorphine

POISONS AND THERAPEUTIC GOODS REGULATION 2008 - REG 92

Supply by pharmacists of liquid methadone or buprenorphine

92 Supply by pharmacists of liquid methadone or buprenorphine

(1A) Despite clause 85, a pharmacist must not supply methadone in oral liquid form or buprenorphine on prescription for the treatment of drug dependence unless--
(a) the methadone or buprenorphine is supplied at the premises of, and in the course of carrying on the business of, a retail pharmacy, and
(b) the retail pharmacy is located on premises at which a pharmacist is approved to supply pharmaceutical benefits under section 90 of the National Health Act 1953 of the Commonwealth.
: Maximum penalty--20 penalty units.
(1) A pharmacist at a retail pharmacy must not, on any particular day, supply any person with methadone in oral liquid form or buprenorphine on a prescription for the treatment of drug dependence if that supply would result in more than 65 persons having been supplied with methadone in oral liquid form or buprenorphine on prescription at that pharmacy on that day.
: Maximum penalty--20 penalty units.
(2) For the purposes of subclause (1), if an amount of methadone in oral liquid form or buprenorphine is supplied for consumption on a day other than the day on which it is supplied, the supply of that amount is taken to have occurred on the day on which the amount is to be consumed.
(3) A person is not to be counted for the purposes of subclause (1) if the person is supplied with an amount of methadone in oral liquid form or buprenorphine that is intended to last the person for at least one week and the person is supplied at that pharmacy with either of those drugs no more than once in any 7 day period.
(4) Subclause (1) does not apply to the supply of methadone in oral liquid form or buprenorphine at a pharmacy in accordance with--
(a) an exemption granted under clause 93, or
(b) a licence issued under Division 3 of Part 8.